NL-OMON23138招募中不适用
BioXmark liquid fiducial markers for image guided radiotherapy in bladder cancer, a safety and performance trial
Amsterdam UMC location AMC0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with histologically proven primary bladder cancer
- •Referred for bladder conserving (chemo-)radiotherapy
排除标准
- •Any contraindication for an cystoscopic procedure
- •Pregnant women
研究者
相似试验
已完成
3 期
BioXmark liquid fiducial markers for image guided radiotherapy in bladder cancer, a safety and performance trialNL-OMON46787Academisch Medisch Centrum20
已完成
不适用
BioXmark, Rectal Feasibility TrialRectal CancerNCT03265418Maastricht Radiation Oncology20
已完成
不适用
BioXmark liquid fiducial to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial10017990rectal tumorNL-OMON47645MAASTRO clinic20
进行中（未招募）
1 期
AN ASSESSMENT OF IMAGING AND CIRCULATING BIOMARKERS IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA TREATED WITH THE ANTI-VEGF MONOCLONAL ANTIBODY BEVACIZUMAB - TRAVASTIN-1. Protocol version 4.0 (20.05.2011)Metastatic colorectal cancerMedDRA version: 14.0 Level: PT Classification code 10056417 Term: Monoclonal antibody unconjugated therapy System Organ Class: 10042613 - Surgical and medical proceduresEUCTR2009-011377-33-GBThe Christie NHS Foundation Trust70
尚未招募
不适用
Bi-directional translation of image based biomarkers between clinical and general populatioo specific disease problem. Improvement of Image-based biomarkers for radiological examinations.DRKS00029308niversitätsklinikum Freiburg50,000